"Neutralization Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).
Descriptor ID |
D009500
|
MeSH Number(s) |
E01.370.225.812.735.550 E05.200.812.735.550 E05.478.594.760.550
|
Concept/Terms |
Neutralization Tests- Neutralization Tests
- Neutralization Test
- Test, Neutralization
- Tests, Neutralization
|
Below are MeSH descriptors whose meaning is more general than "Neutralization Tests".
Below are MeSH descriptors whose meaning is more specific than "Neutralization Tests".
This graph shows the total number of publications written about "Neutralization Tests" by people in this website by year, and whether "Neutralization Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 4 | 4 |
1995 | 0 | 2 | 2 |
1996 | 0 | 1 | 1 |
1998 | 0 | 3 | 3 |
1999 | 0 | 2 | 2 |
2000 | 1 | 1 | 2 |
2001 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2003 | 0 | 4 | 4 |
2004 | 1 | 16 | 17 |
2005 | 1 | 21 | 22 |
2006 | 0 | 16 | 16 |
2007 | 1 | 14 | 15 |
2008 | 0 | 11 | 11 |
2009 | 1 | 4 | 5 |
2010 | 0 | 4 | 4 |
2011 | 0 | 4 | 4 |
2012 | 0 | 3 | 3 |
2013 | 2 | 9 | 11 |
2014 | 2 | 10 | 12 |
2015 | 1 | 2 | 3 |
2016 | 0 | 9 | 9 |
2017 | 6 | 67 | 73 |
2018 | 8 | 63 | 71 |
2019 | 4 | 25 | 29 |
2020 | 19 | 75 | 94 |
2021 | 22 | 124 | 146 |
To return to the timeline, click here.
Below are the most recent publications written about "Neutralization Tests" by people in Profiles.
-
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. 2022 02; 74(2):284-294.
-
Antibodies to SARS-CoV-2 in dogs and cats, USA. Emerg Microbes Infect. 2021 Dec; 10(1):1669-1674.
-
Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2. Emerg Microbes Infect. 2021 Dec; 10(1):1499-1502.
-
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants. Emerg Microbes Infect. 2021 Dec; 10(1):1241-1243.
-
Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro. J Infect Dis. 2021 10 13; 224(7):1109-1114.
-
Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals. J Travel Med. 2021 10 11; 28(7).
-
Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine. J Travel Med. 2021 10 11; 28(7).
-
Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies. J Med Virol. 2022 01; 94(1):399-403.
-
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men. J Infect Dis. 2021 09 01; 224(5):793-797.